Daniel F. Martin, MD
Thomas M. Aaberg Sr. Professor of
Ophthalmology
Director, Section of Vitreoretinal Surgery &
Disease
Medical School
The Johns Hopkins University School of Medicine
Residency and Chief Residency
Emory University School of Medicine
Fellowships
Fellowship in Vitreoretinal Surgery and Diseases at Duke University Eye Center
Two-year fellowship in Uveitis and Ocular Immunology at the National Eye Institute of the National Institutes of Health
Dr. Martin’s primary academic interests have been in the development of new therapies for retinal disease. He has been involved in the design, development, and execution of many clinical trials, having served as principal investigator for more than 25 studies, including AREDS, SOCA, and numerous AMD and diabetes trials. In addition, he has served on numerous clinical trial committees, including three Data and Safety Monitoring Boards and five Steering Committees. Finally, he has served as the study chairman for six national randomized clinical trials. Dr. Martin was extensively involved in the development of the ganciclovir implant and later valganciclovir for the treatment of CMV retinitis and led the clinical trials that resulted in FDA approval of both of these drugs. He has published more than 70 peer-reviewed articles and has delivered more than 130 invited lectures. Dr Martin has been the recipient of numerous awards, including the 2004 Rosenthal Award conferred by the Macula Society for outstanding contributions to his field.
At Emory, Dr Martin has a very active medical and surgical retina practice. In addition to his clinical and research responsibilities, he has served on numerous committees for the American Academy of Ophthalmology, the Macula Society, the Georgia Society of Ophthalmology, the Emory Clinic, and the Emory Eye Center.
